The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Combining two strategies to improve perfusion and drug delivery in solid tumors
Open accessAbstract
Blood perfusion in tumors can be significantly lower than that in the surrounding normal tissue owing to the leakiness and/or compression of tumor blood vessels. Impaired perfusion reduces oxygen supply and results in a hypoxic microenvironment. Hypoxia promotes tumor progression and immunosuppression, and enhances the invasive and metastatic potential of cancer cells. Furthermore, poor perfusion lowers the delivery of systemically administered drugs. Therapeutic strategies to improve perfusion include reduction in vascular permeability by vascular normalization and vascular decompression by alleviating physical forces (solid stress) inside tumors. Both strategies have shown promise, but guidelines on how to use these strategies optimally are lacking. To this end, we developed a mathematical model to guide the optimal use of these strategies. The model accounts for vascular, transvascular, and interstitial fluid and drug transport as well as the diameter and permeability of tumor vessels. Model simulations reveal an optimal perfusion region when vessels are uncompressed, but not very leaky. Within this region, intratumoral distribution of drugs is optimized, particularly for drugs 10 nm in diameter or smaller and of low binding affinity. Therefore, treatments should modify vessel diameter and/or permeability such that perfusion is optimal. Vascular normalization is more effective for hyperpermeable but largely uncompressed vessels (e.g., glioblastomas), whereas solid stress alleviation is more beneficial for compressed but less-permeable vessels (e.g., pancreatic ductal adenocarcinomas). In the case of tumors with hyperpermeable and compressed vessels (e.g., subset of mammary carcinomas), the two strategies need to be combined for improved treatment outcomes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Fibrinolytic therapy helps in dissolving fibrins in occluded vessels and improving the tumor vasculature [32,33,34,35,36].”
From Approaches to Improve EPR-Based Drug Delivery for Cancer Therapy and Diagnosis (2023) · cites this paper as [36]
Citations
Cites
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Conroy, T., Desseigne, F., Ychou, M., Bouché, O., Guimbaud, R., Bécouarn, Y., Adenis, A., Raoul, J.-L., Gourgou-Bourgade, S., de la Fouchardière, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1011923 · Cited by 7,810
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527
Olive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., Madhu, B., Goldgraben, M. A., Caldwell, M. E., Allard, D., et al. (2009) · Science · doi:10.1126/science.1171362 · Cited by 3,170
Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment
Hobbs, S. K., Monsky, W. L., Yuan, F., Roberts, W. G., Griffith, L., Torchilin, V. P., & Jain, R. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4607 · Cited by 2,438
Provenzano, P. P., Cuevas, C., Chang, A. E., Goel, V. K., Von Hoff, D. D., & Hingorani, S. R. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.01.007 · Cited by 2,195
Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy
Jain, R. K. (2001) · Nature Medicine · doi:10.1038/nm0901-987 · Cited by 2,184
Gradishar, W. J., Tjulandin, S., Davidson, N. G. P., Shaw, H., Desai, N. P., Bhar, P., Hawkins, M., & O’Shaughnessy, J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.937 · Cited by 2,159
EMT and Dissemination Precede Pancreatic Tumor Formation
Rhim, A. D., Mirek, E. T., Aiello, N. M., Maitra, A., Bailey, J. M., McAllister, F., Reichert, M., Beatty, G. L., Rustgi, A. K., Vonderheide, R. H., et al. (2012) · Cell · doi:10.1016/j.cell.2011.11.025 · Cited by 2,136
Batchelor, T. T., Sorensen, A. G., di Tomaso, E., Zhang, W.-T., Duda, D. G., Cohen, K. S., Kozak, K. R., Cahill, D. P., Chen, P.-J., Zhu, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.11.021 · Cited by 1,769
O’Brien, M. E. R., Wigler, N., Inbar, M., Rosso, R., Grischke, E., Santoro, A., Catane, R., Kieback, D., Tomczak, P., Ackland, S. P., et al. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh097 · Cited by 1,739
Cited by
Sorted by citations
Items 401–500 of 506
Tumor Effect‐Site Pharmacokinetics: Mechanisms and Impact on Efficacy
Thurber, G. M. (2015) · Pharmaceutical Sciences Encyclopedia · doi:10.1002/9780470571224.pse551 · Cited by 3
Islam, M. T., Tasciotti, E., & Righetti, R. (2018) · arXiv (Cornell University) · doi:10.48550/arxiv.1809.03663 · Cited by 3
Mirala, F., & Soltani, M. (2025) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2025.111388 · Cited by 2
Computational Fluid Dynamics Simulations to Inform Cancer Therapeutics
Roncali, E., & Taebi, A. (2026) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-110824-021423 · Cited by 2
DeepONet-enhanced bayesian inference for biphasic tumor growth modeling
Sotiropoulos, G., Litvinov, S., Kaltenbach, S., Harkos, C., Atzarakis, K., Stylianopoulos, T., Koumoutsakos, P., & Papadopoulos, V. (2026) · Computer Methods in Applied Mechanics and Engineering · doi:10.1016/j.cma.2026.118919 · Cited by 2
Focused ultrasound for cellular mechanoactivation and nanomedicine delivery in cancer
Luo, A. C., Qian, Z., & King, M. R. (2026) · Biomedical Microdevices · doi:10.1007/s10544-026-00817-x · Cited by 2
Liu, D., Guo, L., Waasdorp, C., Meijer, S. L., Bootsma, S., Oyarce, C., Bijlsma, M. F., & van Laarhoven, H. W. M. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117261 · Cited by 2
Engineered model of tumor microenvironment for replicating intratumoral drug delivery
Besanjideh, M., Zarei, F., Rezaeian, M., & Shamloo, A. (2025) · Journal of Industrial and Engineering Chemistry · doi:10.1016/j.jiec.2025.06.023 · Cited by 2
Delivery of Cancer Nanotherapeutics
Chung, B. L., Kaplinsky, J., Langer, R., & Kamaly, N. (2018) · Bioanalysis · doi:10.1007/978-3-030-01775-0_8 · Cited by 2
Targeted delivery of nanoparticles
Rotem, R., Prosperi, D., & Colombo, M. (2020) · Frontiers of nanoscience · doi:10.1016/b978-0-08-102828-5.00010-3 · Cited by 2
The Klein–Gordon equation in mixture models of tumour growth
Caviglia, G., Morro, A., & Pinamonti, N. (2014) · Physics Letters A · doi:10.1016/j.physleta.2014.10.018 · Cited by 2
Mohebali, M., Rezapour, N., Shadmani, P., & Montazeri, A. (2020) · Journal of Molecular Modeling · doi:10.1007/s00894-020-04487-1 · Cited by 2
Delivery of radioimmunotherapy for solid tumors
Gautam, S. K., Dalal, V., Jain, M., & Batra, S. K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85781-9.00016-6 · Cited by 2
Wang, X., Chen, X., Zhu, J., & Li, S. (2024) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2024.112033 · Cited by 1
Salazar, F. M. V., & Arcila, I. D. P. (2025) · PLoS ONE · doi:10.1371/journal.pone.0315194 · Cited by 1
Wang, X., Hong, H., Cao, W., Cheng, X., Li, L., Hu, M., Wang, J., Li, J., Ni, Q., Wang, X., et al. (2025) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2025.114941 · Cited by 1
MicroRNA-Induced Regulation of the IGF-1 System in Various Types of Cancer
Triantafyllou, G., Kategianni, M., Maridaki, M. D., Koutsilieris, M., & Philippou, Α. (2025) · Genes · doi:10.3390/genes16101135 · Cited by 1
Feasibility and efficacy of electromotive intraperitoneal drug delivery: A hybrid study
Saeed, N., Salavati, H., Min, J. W. S., Cosyns, S., Remaut, K., Debbaut, C., Adriaens, M., Coene, A., & Ceelen, W. P. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118619 · Cited by 1
Mirala, F., & Soltani, M. (2026) · Drug Delivery and Translational Research · doi:10.1007/s13346-026-02051-7 · Cited by 2
Tumor-on-chip platforms for transport phenotyping: decoding CAF-driven barriers to drug delivery
Manach, D. L., Senez, V., & Nees, M. (2026) · Lab on a Chip · doi:10.1039/d5lc01131k · Cited by 1
Zhu, Y., Zhu, X., Huang, D., Ji, Y., Wang, R., Li, Y. F., Luo, Y. F., Luo, Y., Zhuang, Y., Liu, Z., et al. (2026) · npj Precision Oncology · doi:10.1038/s41698-026-01423-z · Cited by 1
Nguyen-Vigouroux, C., Carraz-Billat, E., Cetenovic, T., Galleri-Paris, C., Protin, J., Canet-Jourdan, C., Dornier, E., Polrot, M., Cartry, J., Boilève, A., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117523 · Cited by 1
Singh, F. (2026) · Biomedical Microdevices · doi:10.1007/s10544-026-00832-y · Cited by 2
Singh, A. K., Kaur, N., Desai, N., Ankush, A., Meena, L. P., Chauhan, K., Vora, L. K., & Prasad, R. (2026) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6c00162 · Cited by 1
Singh, D. (2026) · Carbohydrate Research · doi:10.1016/j.carres.2026.110029 · Cited by 1
Rauf, M. A., Luong, D., Shah, F., & Iyer, A. K. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1914117 · Cited by 1
Hoang, T. A., Lee, E., Hwang, D., Cho, H. J., & Park, S. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.115345 · Cited by 1
Mathematical Modeling of Two-dimensional Unsteady Flow in Growing Tumor
Gracia, A., Riahi, D. N., & Roy, R. (2015) · Applications and Applied Mathematics: An International Journal (AAM) · Cited by 1
Clinical applications of microRNAs
Thillaiyampalam, G., & Cristino, A. S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89774-7.00013-3 · Cited by 1
Mahmoodi, M., Pishevar, A., & Azargoshasbi, F. (2023) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2023.111633 · Cited by 1
FOXP3 is a favourable prognostic indicator in oesophageal adenocarcinoma
Bates, M., McGrath, J., Byrne, L., Vishwakarma, R., Dinneen, K., Mhaolcatha, S. N., Greene, J. P., Selvadurai, P. N., Donlon, N. E., Bhardwaj, A., et al. (2025) · Pathology - Research and Practice · doi:10.1016/j.prp.2025.156216 · Cited by 1
Porous Silicon Nanoparticles for Applications in Nano-medicine
Kafshgari, M. H., Voelcker, N. H., & Harding, F. J. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-803581-8.10463-1 · Cited by 1
Kitada, A., Shaji, M., Irisa, T., Fujimoto, K., Karsten, S. L., & Yokokawa, R. (2023) · IEEJ Transactions on Sensors and Micromachines · doi:10.1541/ieejsmas.143.82
Duda, D. G., Heist, R. S., Sahani, D. V., Stylianopoulos, T., Engelman, J. A., & Jain, R. K. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1507225112 · Cited by 1
Gargini, R., Segura-Collar, B., Hernández-SanMiguel, E., Garcia-Escudero, V., Romero-Bravo, A., Herránz, B., Núñez, F. J., García-Pérez, D., Ayuso-Sacido, A., Seoane, J., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/541326 · Cited by 2
Bernabéu, M. O., Köry, J., Grogan, J. A., Markelc, B., Beardo, A., d’Avezac, M., Enjalbert, R., Kaeppler, J., Daly, N., Hetherington, J., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/640060 · Cited by 1
Niche inheritance: a cooperative pathway to enhance cancer cell fitness though ecosystem engineeringPreprint
Yang, K. R., Mooney, S. M., Zarif, J. C., Coffey, D. S., Taichman, R. S., & Pienta, K. J. (2014) · arXiv (Cornell University) · doi:10.48550/arxiv.1403.7413 · Cited by 1
Going Beyond VEGF Pathway Inhibition for Antiangiogenic Cancer Therapy
Martin, J. D., Duda, D. G., & Jain, R. K. (2020) · Circulation Research · doi:10.1161/circresaha.120.317720 · Cited by 1
Letter to the editor regarding recent article by Wu et al. [J. Theor. Biol. 355 (2014) pp. 194–207]
Jain, R. K., & Netti, P. A. (2014) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2014.08.052
Translation in Cancer at Hypoxia
Yi, T., & Wagner, G. (2014) · Springer eBooks · doi:10.1007/978-94-017-9078-9_20
Tyson, R., Osae, L., Madden, A. J., Lucas, A. T., & Zamboni, W. C. (2016) · Wiley eBooks · doi:10.1002/9783527800681.ch19
Gonzalez, A. M. P. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2017.tde-03032017-094509
Korth, M. (2017) · OPen Access Repositorium der Universität Ulm (OPARU) (Ulm University) · doi:10.18725/oparu-4364
Emerging therapies for the treatment of cholangiocarcinoma
Turbeville, S. D., Hornfeldt, C. S., Javle, M. M., Tran, E., & Schwartz, M. (2017) · International Journal of Hepatobiliary and Pancreatic Diseases · doi:10.5348/ijhpd-2017-72-ra-8
Kerketta, R. (2017) · UNM’s Digital Repository (University of New Mexico)
Barriers for Tumor Drug Delivery
Huang, Q., & Du, J. (2020) · Springer eBooks · doi:10.1007/978-981-15-5159-8_2
Monitoring cancer cell surface receptor expression during anti-angiogenesis therapy in vivo
Meng, B., Strawbridge, R. R., Tichauer, K. M., Samkoe, K. S., & Davis, S. C. (2021) · Molecular-Guided Surgery: Molecules, Devices, and Applications · doi:10.1117/12.2583237
Ren, T., Jia, H., Wu, Q. D., Zhang, Y., Ma, Q., Dong, Y., Gao, X., Xie, D., Xu, Z., Zhang, Y., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-830539/v1
Li, C. Z. C., Wang, Y., Ghidan, A. Y., & Antary, T. M. A. (2021) · Indian Journal of Pharmaceutical Sciences · doi:10.36468/pharmaceutical-sciences.860
Designing novel therapeutic strategies against tumor stroma and fibrosis
Mardhian, D. F. (2021) · doi:10.3990/1.9789036553179
Cubbon, R. M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.99736-8
Coles, M. C., & Brown, L. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.733699856.793549350
孙, 立. (2020) · Advances in Clinical Medicine · doi:10.12677/acm.2020.103063
Akash, M. M. H., Chakraborty, N., Mohammad, J., Reindl, K. M., & Basu, S. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.05.30.494072
Datta, M., Kennedy, M., Via, L. E., Baish, J. W., Xu, L., Dartois, V. A., Clifton E. Barry, 3., & Jain, R. K. (2023) · Research Square · doi:10.21203/rs.3.rs-2464284/v1
Expression of gemcitabine metabolizing enzymes in different pancreatic cancer model systems
Knoll, L. (2023) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-9800
Martin, J. D., Lanning, R. M., Chauhan, V. P., Martin, M. R., Mousa, S. M., Kamoun, W. S., Han, H., Lee, H., Stylianopoulos, T., Bawendi, M. G., et al. (2023) · doi:10.1158/1078-0432.c.6532584.v1
Nanotechnology and Precision Medicine
Alonazi, N. A., Albukhari, T. A., & Alruwaili, N. M. (2023) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815124606123010008
Yin, D., Sun, Q., Li, Y., Shen, W. H., Shang, W., Xu, Y., Yang, J., Chen, J., Gao, W., Wu, Q., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3259314/v1
Zhang, Y., Zhang, J., Luo, T., Tan, X., Li, P., Dong, X., Zhu, Q., & Liu, Z. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.105059
CFD simulation of blood-mediated drug transport through a dense solid tumour
Kedia, K., Khan, A. A., Mukherjee, S., & Mallick, A. (2024) · Indian Chemical Engineer · doi:10.1080/00194506.2024.2370866
CDK5 affects the resistance of lung cancer to radiotherapy by altering the tumor microenvironment
Chen, H., Xu, C.-W., Wang, W.-X., Chen, P., Li, X.-F., Lan, G., Zhai, Z., Zhu, Y.-C., Du, K., & Huang, L.-C. (2024) · Journal of Radiation Research and Applied Sciences · doi:10.1016/j.jrras.2024.101104 · Cited by 2
Advanced Drug Delivery Against Colorectal Cancer by Biopolymeric Nanoparticle Formulations
Mukherjee, S., & Karati, D. (2025) · Regenerative Engineering and Translational Medicine · doi:10.1007/s40883-025-00487-w
Di‐Luoffo, M., Arcucci, S., Therville, N., Marty, T., D’Angelo, R., Chaouki, M., Thibault, B., Swider, P., Assémat, P., Delarue, M., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.23.681444
Multiscale analysis of electrically stimulated vascularised tumours
Fülöp, Z. B., & Penta, R. (2025) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2025.112307
Yang, F., Peng, C., Yang, S., Bian, X., & Yao, X. (2025) · Pathology - Research and Practice · doi:10.1016/j.prp.2025.156305
Majumder, S., Khan, M. H. R., Chua, C. Y. X., Taraballi, F., & Righetti, R. (2025) · PNAS Nexus · doi:10.1093/pnasnexus/pgaf354
Beldek, E., Holtz, M., Denizli, A., & Usta, O. B. (2025) · Comprehensive physiology · doi:10.1002/cph4.70082
Fasaeiyan, N., Soltani, M., Kashkooli, F. M., Taatizadeh, E., & Rahmim, A. (2021) · Figshare · doi:10.6084/m9.figshare.17084393
Nanomedicine for Conjugated Therapy and Diagnosis in Cancer Treatment
Sahoo, P., Das, M., Adhikari, S., Mukherjee, A., & Ghosh, C. K. (2025) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898813123125010009
Dhole, R., Pawar, M., Ahirrao, B., Chhabra, G. S., Fnu, P. I. J., Nalla, S., Darji, P., & Patel, B. (2025) · Biosciences Biotechnology Research Asia · doi:10.13005/bbra/3457
Alam, M., Dey, B., Byrne, H. M., & Sekhar, G. P. R. (2026) · Journal of Mathematical Biology · doi:10.1007/s00285-026-02362-w
Akash, M. M. H., Yeasin, M., Mahmoudirad, S., Niloy, R. A., Mohammad, J., Reindl, K. M., Pandey, A., & Basu, S. K. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1746751
Etude et inhibition de l'activation endothéliale au cours de l'angiogenèse
Cossutta, M. (2017) · theses.fr (ABES) · doi:10.70675/b2ab1c80zb5caz47c4za53bz83c66b494fda
Immuno-modulatory functions of tenascin-C in a tumor progression model
Murdamoothoo, D. (2018) · theses.fr (ABES) · doi:10.70675/0ebddce2z280az4c92z9177z76ee60326851
Saccone, M. A. (2019) · theses.fr (ABES) · doi:10.70675/d8995276z6866z4372zbbc2z271914e8a438
Mathematical modeling of antibody nanoconjugates transport in tumors
Vaghi, C. (2020) · theses.fr (ABES) · doi:10.70675/b385c631za830z412dzb918zb2d2f5181f67
Nanomedicine guided by spatial omics: A next-generation approach to precision drug delivery
Menon, G., Malave, B., Parjane, S., Mhaismale, H., & Narayanan, V. A. (2026) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2026.108306
Mechanobiology of cancer-associated thrombosis: from molecular mechanisms to therapeutic innovation
Wang, Z. T., Hu, Y. R., Zhan, Z., Dupuy, A., Yao, Z., Liu, X., & Ju, L. A. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04411-4
PID controller system development to enhance hyperthermia-mediated drug delivery
Adabbo, G., Andreozzi, A., Iasiello, M., Napoli, G., & Vanoli, G. P. (2026) · Applied Mathematical Modelling · doi:10.1016/j.apm.2026.117031
Solopov, P. A., Enos, A., Šilkūnas, M., Šilkūnienė, G., Zivla, E., Pakhomov, A. G., & Pakhomova, O. N. (2026) · Cancers · doi:10.3390/cancers18101540
Warmke, N., Walker, A., & Cubbon, R. M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-15734-9.00160-6
Fan, Y., Aji, A., Feng, T., Jiang, L.-B., & Ta, D. (2026) · Ultrasonics · doi:10.1016/j.ultras.2026.108177
Vayakkattil, A. B., Pazhanchery, A. S., Vijayarajan, V., & Vayakkattil, U. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1848102
Sonopermeation to Overcome Barriers for Delivery of Drugs to Tumors and Brain Tissue
Davies, C. D. L., & Snipstad, S. (2026) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-026-00928-8
Koutsi, M., Mpekris, F., & Stylianopoulos, T. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1937764
Functional heterogeneity of macrophages in distinct niches of hepatocellular carcinoma
Guo, J., Li, J., Comps‐Agrar, L., Turley, S. J., & Fu, W. (2026) · Trends in Immunology · doi:10.1016/j.it.2026.06.009
Locoregional Therapy Pressure-Enabled Drug Delivery for Liver Cancers
Eggleston, T., Fayek, F. B., Kowalke, J., & Makary, M. S. (2026) · Cancers · doi:10.3390/cancers18152367
Azo-based compounds for hypoxia-responsive drug delivery
Nasiri, S., & Najjar, R. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-33641-6.00015-4
Physical Limits of Proximal Tumor Detection via MAGE-A Extracellular Vesicles
Okcu, A. S., Bas, M. E., & Akan, Ö. B. (2026) · IEEE Transactions on Molecular Biological and Multi-Scale Communications · doi:10.1109/tmbmc.2026.3719283
Choi, W. J., Hwang, J., Kong, C., Han, S., Baek, J., Kim, J., Chang, W. S., & Moon, S. (2026) · Scientific Reports · doi:10.1038/s41598-026-62684-z
Tisza, A., Török, S., Sugihara, Y., Horváth, Z., Gellert, Á., Bugyik, E., Berta, J., Kovács, I., Bárány, N., Marko‐Varga, G., et al. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.179293
Tumor microenvironment targeted drug delivery systems
Kumar, L., Morya, N., Hirave, K. S., Sharma, M., & Saharan, V. A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-44185-1.00008-2
Harkos, C., Munn, L. L., Stylianopoulos, T., & Jain, R. K. (2026) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2026-015357
Shao, Y., Hu, J., Li, Y., Zhu, X., Li, J., Zheng, L., Zhao, D., Li, L., Lin, M., Shao, J., et al. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1925984
Targeting extracellular matrix mechanobiology to suppress solid tumor progression
Boone, K., Kondapaneni, R. V., Libring, S., & Reinhart‐King, C. A. (2026) · Cancer Letters · doi:10.1016/j.canlet.2026.218856
Metadata
- Authors
- Stylianopoulos, T., & Jain, R. K.
- Affiliations
- University of Cyprus (CY)
- Harvard University (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2013-10-28
- Volume
- 110
- Issue
- 46
- Pages
- 18632-18637
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC3832007
- OpenAlex
- W1964128680
- Cited by
- 508
- References
- 67
- Citations by year
- 2026: 49 · 2025: 46 · 2024: 45 · 2023: 47 · 2022: 29 · 2021: 35 · 2020: 53 · 2019: 29 · 2018: 39 · 2017: 35 · 2016: 34 · 2015: 47 · 2014: 19 · 2013: 1
- FWCI
- 34.83
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- other-oa
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (R01CA115767, T32CA073479, R01CA085140, R01CA096915, P01CA080124, R01CA126642, R01CA098706)
- Topics
- Physical Sciences › Mathematics › Modeling and Simulation › Mathematical Biology Tumor Growth
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- tumor perfusion, drug delivery, solid tumors, vascular normalization, solid stress, tumor hypoxia, vascular permeability, interstitial fluid flow, mathematical model, drug distribution, glioblastoma, pancreatic ductal adenocarcinoma, breast cancer
- MeSH terms
- Biomechanical Phenomena, Capillary Permeability, Computer Simulation, Humans, Models, Biological, Neoplasms, Regional Blood Flow, Drug Delivery Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review